Harmony Biosciences Announces Positive Results From the Pivotal Bioequivalence Study for Pitolisant Gastro-Resistant Formulation
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Nov. 24, 2025-- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced positive results from...